Wells Fargo Maintains Overweight on Visteon, Lowers Price Target to $137

Benzinga Newsdesk www.benzinga.com Negative 87.4%

Neg 87.4% Neu 0% Pos 0%

Wells Fargo analyst Colin Langan maintains Visteon (NASDAQ:VC) with a Overweight and lowers the price target from $139 to $137.